Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9 Prostatic Neoplasms, Castration-Resistant 6 Metastatic Castration-resistant Prostate Cancer 2 Pain 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Fractures, Bone 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Bony Metastases From Castrate Refractory Prostate Cancer 1 Bone Neoplasms 1 Bone Metastatic Castration-resistant Prostate Cancer 1 Advanced Prostate Cancer 1

Interventions

radium Ra 223 dichloride 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Advanced Prostate Cancer × radium Ra 223 dichloride × Clear all

NCT02925702 2020-01-27

PRORADIUM

Centro Nacional de Investigaciones Oncologicas CARLOS III

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡